cell pharm GmbH Company Profile

02:20 EDT 26th April 2015 | BioPortfolio



Email: info@cellpharm.com

News Articles [1062 Associated News Articles listed on BioPortfolio]

Chinese regulator approves D-Pharm epilepsy drug trial

D-Pharm has teamed with China's Nhwa Pharmaceutical in developing DP-VPA.

Russia’s R-Pharm to invest $50 million in development of new drugs and vaccines

R-Pharm, one of Russia’s largest pharmaceutical producers, together with Russian Venture Company (RVC) have officially announced the establishment of a venture capital fund that will focus on fundin...

Bukwang Pharm Appoints Korea's First Woman CEO

Yu Hee-won has been appointed as co-president and CEO of Korean-based Bukwang Pharm.

Re-Pharm identifies novel anti-inflammatory activity for existing compound

Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce the identification of RP0217 as an effective new anti-inflammat...

University of Florida's Pharm.D. program highlights risks associated with APAP

Michael JohnsenThe University of Florida's Pharm.D. program recently released an infographic around the risks associated with acetaminophen use.  read more

Re-Pharm Uses Cresset’s Forge to Identify Novel Activity for an Existing Drug

Cresset, innovative provider of computational chemistry software and services, announces that its drug discovery arm Re-Pharm Ltd has used Forge to identify novel anti-inflammatory activity for an exi...

What’s Ahead for 2015? Pharm Exec's Industry Outlook

Pharm Exec’s annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead. read more

Russia’s R-Pharm in deals with AbbVie and Bristol-Myers for local production

US drugmaker AbbVie has joined forces with Russia’s R-Pharm to establish the joint production of Kaletra…

PubMed Articles [3604 Associated PubMed Articles listed on BioPortfolio]

To Conduct Clinical Trial in China, To Go or Not To Go.

In last 10 years, more and more clinical trials have come to China because of potential market/easy access of patient and cost-effectiveness, but looking back, there is less change on the regulatory r...

Exercise Prescription: Who Is the Pharm D?

Cover picture: arch. Pharm. Chem. Life sci. (1/2015).

Editorial board: arch. Pharm. Chem. Life sci. (1/2015).

SIRT1 Synchs Satellite Cell Metabolism with Stem Cell Fate.

Metabolic reprogramming of muscle stem cells modulates myogenic cell fate. In this issue of Cell Stem Cell, Ryall et al. (2015) show that SIRT1, a NAD(+)-dependent histone deacetylase, acts as an epi...

Clinical Trials [3266 Associated Clinical Trials listed on BioPortfolio]

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

This open-label, Phase I study will evaluate the safety, tolerability, and pharm acokinetics of increasing doses of GDC-0853 in patients with relapsed or refract ory B-cell non-Hodgkin's l...

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Belotecan (Camtobell, CKD-602, Chong Kun Dang Pharm., Korea) is a new camptothecin derivative, that exhibits anticancer effects by inhibiting topoisomerase I. The investigators will have a...

Comparison Study of Intravenous (IV) Versus Oral Iron (Fe) for Iron Deficiency Anemia Treatment in Late Pregnancy

The purpose of this study is to compare the efficacy of treatment between intravenous iron sucrose and oral iron fumarate in pregnant women in the third trimester.

Cognitive Adaptive Training for Improving Medication Adherence, Symptoms, and Function in People With Schizophrenia

This study will compare the effectiveness of three treatments in improving medication adherence, symptoms, and function in people with schizophrenia.

A Phase 1, Randomized, Double-blind, Placebo-controlled Crossover Study of RG7314 on the Potential Regulation of Higher Brain Functions in Healthy Male Participants: Proof of Mechanism

This is a single site, randomized, double-blind, three period cross-over, placeb o-controlled, proof of mechanism study in healthy male subjects. The study will investigate whether the dir...

Companies [902 Associated Companies listed on BioPortfolio]

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

cell pharm GmbH


Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...


Pharm-Chem.com is a special directory of the chemical and medicine industries, offering up-to-date information of China chemical and medicine manufacturers and suppliers as well as the news and the la...

Pharm PlanNet Contract Research GmbH

Pharm PlanNet Contract Research GmbH (Pharm PlanNet) was founded in 1992 as an independent and privately owned Clinical Research Organisation offering its service to the pharmaceutical industry. Pharm...

More Information about "cell pharm GmbH" on BioPortfolio

We have published hundreds of cell pharm GmbH news stories on BioPortfolio along with dozens of cell pharm GmbH Clinical Trials and PubMed Articles about cell pharm GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of cell pharm GmbH Companies in our database. You can also find out about relevant cell pharm GmbH Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record